Stem cells are the next frontier in the treatment of orthopaedic and spinal disorders, and the Cary Orthopaedics team is leading the way.
Using stem cells harvested from an adult patients own bone marrow,Dr. Sameer Mathurand Dr. Nael Shanti both board-certified orthopaedic spinal surgeons have developed a minimally invasive remedy for those suffering from degenerative disc disease, back pain and spinal arthritis. Applying a similar approach, Cary OrthosDr. Douglas Martini a fellowship-trained, board-certified orthopaedic surgeon specializing in sports medicine has crafted a pain-relief solution for patients living with osteoarthritis and soft tissue injuries.
Multiple research studies have shown a significant reduction in low back and joint pain and improved function after stem cell injections. While these treatments are new, 80% to 90% of patients are already reporting improvement in their symptoms after orthopaedic stem cell treatments.
Many patients suffering from degenerative disc diseases or low back pain are often not ideal candidates for surgery, and some who have chosen to undergo surgery have had unsatisfactory results. Therefore, the typical remedy for chronic orthopaedic conditions is extensive physical therapy combined with oral anti-inflammatory medications. The result: The majority of patients still had to live with pain.
Physicians at Cary Orthopaedics are utilizing orthopaedic stem cell treatment using the patients own bone marrow, the soft, spongy tissue found in the center of bones. Bone marrow in adults contains a rich reservoir of multipotent stem cells also known as Mesenchymal Precursor Cells (MPCs) that can be extracted from the patients pelvis or hip bone. Due to their unique, regenerative composition, these cells can become various types of tissues including soft tissue, bone or cartilage, which make them an excellent resource for repairing and rebuilding damaged tissue, accelerating the healing process and improving overall function.
Thanks to advancements in technology, the removal and harvesting process has become easier and less expensive. Since this is a minimally invasive procedure, it has fewer side effects compared to traditional surgery, and it causes minimal discomfort to the patient.
Bone marrow injections are a breakthrough for patients in pain. Dr. Martini, a sports medicine physician at Cary Orthopaedics, has been active in the sports medicine community, previously serving as team physician for the Carolina Hurricanes, numerous colleges, and local high schools. After 25 years of experience in sports medicine, he realizes the need for improved treatment options for the greying athlete. He has begun incorporating bone marrow aspirate concentrate (BAC) into the treatment of both acute and chronic soft tissue and joint-related injuries. I believe this will be equally helpful to the patient who needs to exercise for overall health benefits as it would be for those who need to stay at their peak athletic performance, says Dr. Martini.
We have found based on our research and experience that stem cell therapy can be very safe and effective when used with the appropriate patient population, said Kevin G. Morrison, PA-C, a member of Dr. Martinis team. All the feedback to this point has been quite positive, both on the process of having the procedure done as well as the early response. But ultimately long-term data will need to be compiled and critically examined.
Much of the previous research into stem cells has centered around placental stem cells, which can also adapt into other types of tissues. However, these have not performed well when put to the test for orthopaedic treatment. Bone marrow aspirate concentrate provides MPCs that can transform into osteocytes, chondrocytes and adipocytes, all of which are important in treating orthopedic conditions.
The latest research around mesenchymal stem cells, specifically bone marrow aspiration, is certainly promising. Dr. Martini will continue to collect more data and review patients responses.
Dr. Mathur has been an instrumental force in elevating the level of patient care at Cary Orthopaedic Spine Center since joining the practice in 2008. Dr. Mathur completed his medical school at the University of Pennsylvania and spinal reconstructive fellowship at the Rush University Medical Center in Chicago. He also taught at Dana Farber Cancer Institute in Boston. Over the last 10 years, in conjunction with the National Institutes of Health, he has conducted significant study of disc degeneration and analysis of the expression of genes that may damage the disc.
In the past decade, there have been several advancements in spinal surgery, but regenerative medicine is the next frontier, said Dr. Mathur. I see so many patients that have low back pain and leg pain from degenerative disc disease. For many, there is no good surgical treatment, and stem cell injections may be a viable option.
As an orthopaedic spine specialist, Dr. Mathur is not only an expert in spinal surgery but also in the diagnosis and treatment of a wide range of spinal problems. His depth of experience allows him to best determine whether a patient would benefit from physical therapy, stem cell injections or surgical intervention. When providing stem cell treatment, Dr. Mathur performs a single injection for all patients, whereas other clinics typically require multiple injections over several weeks.
There is currently extensive, ongoing research on the application of stem cell therapy and tissue regeneration, including an application for spinal cord injury and disc pathology, which is very exciting, said Dr. Shanti, who has dedicated a great deal of time researching the potential impact stem cell therapy can provide for his patients. Dr. Shanti believes stem cell therapy is the next great advancement in healthcare with an application for a wide spectrum of medical conditions.
Recently recognized as Top Orthopaedic Doctor by The Leading Physicians of the World for the outstanding patient care, Dr. Shantis in-depth experience and understanding of the spine allows him to guide his patients especially those with chronic back pain to the most appropriate path of treatment with the shared collaborative goal of pain relief. Dr. Shanti completed his spine surgery fellowship training at the prestigious New England Baptist Hospital, Tufts University program with an emphasis on minimally invasive spine surgery, and he has authored and presented multiple papers and textbooks on the advancement of minimally invasive spine surgery.
Orthopaedic stem cell treatment is an excellent solution for patients with degenerative disc disease and also those suffering from arthritis of the spine, bulging disc, low back pain, facet joint pain or disc with annular tears.
The stem cell injection is a same-day procedure that generally takes one hour to perform. The actual extraction of bone marrow takes up to 10 minutes. The bone marrow extraction site typically the back of the patients hip or pelvis bone is numbed using a mixture of local anesthetics. A suctioned syringe is attached to a long needle that reaches the posterior aspect of the hip. The patient may experience a minimal amount of discomfort during the extraction.
The sample is collected, transferred through a filter, and then placed into a centrifuge for spinning. The speed separates the stem cells and platelets from the bone marrow. This concentration of stem cells is then reintroduced into the degenerative or painful area under image guidance with fluoroscopy to confirm accurate placement.
The harvesting site will be numb for 1 to 2 hours after the procedure, so the patient will need to have transportation home. It is permissible to fly after the treatment, but this may cause increased pain or discomfort.
Stem cell therapy relies on the bodys own regenerative process to heal, which takes time. Patients have seen the benefits in two to three months after treatment; however, many have noticed improvements in symptoms sooner.
The recommended age range for the treatment is 20 to 70 years old. As the body ages, the quality and quantity of stem cells slowly decline. After age 70, patients may experience a sharper decline in stem cells, resulting in less beneficial outcomes.
If you think you might be a candidate for orthopaedic stem cell therapy treatment, contact Cary Orthopaedics to schedule a consultation.
Original post:
Cary Ortho Utilizes Bone Marrow Stem Cells for General ...
- Kyle Orwig received the Distinguished Researcher Award from the American Society for Reproductive Medicine - University of Pittsburgh - October 4th, 2022
- I Have Cancer And I'm Thankful For The Life Science Industry - Clinical Leader - July 19th, 2022
- Whitmer to veto adoption, abortion alternative funds from Michigan budget - Bridge Michigan - July 19th, 2022
- Tevogen Bio Appoints Acclaimed Oncologist and Immunotherapy Expert Neal Flomenberg, M.D. as Chief Scientific Officer and Global Head of R&D - Yahoo... - July 11th, 2022
- Amendment added to PA budget bill would make Pitt, other universities stop fetal tissue research - WPXI Pittsburgh - July 3rd, 2022
- Free Fecal Water Syndrome in Horses and What To Do About It The Horse - TheHorse.com - July 3rd, 2022
- PAWcast: Valedictorian Natalia Orlovsky '22 on Research, Mental Health, and Pandemic Princeton - Princeton Alumni Weekly - July 3rd, 2022
- Opinion | Pro-Life Representatives may be the reason thousands of students cant afford Pitt - The Pitt News - June 22nd, 2022
- Tackling chronic disease with gene and cell therapies - The Irish Times - May 2nd, 2022
- How one inflammatory disorder exacerbates another | Penn Today - Penn Today - May 2nd, 2022
- ChristianaCare and The Wistar Institute Advance Partnership With New Cancer Research Strategies - ChristianaCare News - March 25th, 2022
- The Incredible Story of Emily Whitehead & CAR T-Cell Therapy : Oncology Times - LWW Journals - March 25th, 2022
- Penn State recipients of Whitaker Center's Women of Impact 2021 awards unite through research - The Daily Collegian Online - March 25th, 2022
- Citius Pharmaceuticals to Host Key Opinion Leader Webcast on the Compelling Need to Salvage Central Venous Catheters in CLABSI Patients - Stockhouse - October 28th, 2021
- NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases - National Institutes of Health - October 28th, 2021
- FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases - FDA.gov - October 28th, 2021
- People and places at Penn | Penn Today - Penn Today - Penn Today - August 18th, 2021
- Millions in federal money flowed to tissue bank that collected fetal 'heart, gonads, legs, brain': report - Fox News - August 5th, 2021
- Bispecific Antibodies Wage a Two-Pronged Attack on Tumors - Curetoday.com - June 23rd, 2021
- Newly Discovered Glycosylated RNA Is All Over Cells: Study - The Scientist - May 25th, 2021
- Penn researchers find a way through the labyrinth keeping CAR-T from solid tumors - Endpoints News - December 7th, 2020
- 'Benjamin Button' discovery could reverse ageing process - Queensland Times - December 7th, 2020
- The story of mRNA: From a loose idea to a tool that may help curb Covid - STAT - November 11th, 2020
- Dr. Andreas Sauerbrey: The right orthopaedic diagnosis is essential to proper care - Sky Hi News - September 12th, 2020
- T cells, B cells and the range of the human bodys immune response A simple decoder - ThePrint - August 10th, 2020
- Are very long-lived trees immortal and what can they teach humans? - ABC News - August 10th, 2020
- Eradicating balding a step closer with new procedure in the cross hairs - The New Daily - June 4th, 2020
- Coming Together to Solve COVID-19 Mysteries | University of Pennsylvania Almanac - UPENN Almanac - June 4th, 2020
- Orthopedics - Pennsylvania Stem Cell Center - May 25th, 2020
- Stem Cell Treatment Bala Cynwyd | Stem Cell Therapy ... - May 25th, 2020
- Vasomune Therapeutics Announces Clinical and Scientific Advisory Board - BioSpace - May 11th, 2020
- Chinas scientists accused of playing God by creating monstrous cloned apes and primates with human organs - The Sun - May 11th, 2020
- Pregnant and positive | Scientists look for COVID-19 immunity in the womb - WHAS11.com - April 23rd, 2020
- Why Choose Us - Pennsylvania Stem Cell Center - April 10th, 2020
- Moderna: A $12 Billion Brand Built On Hope And mRNA - Seeking Alpha - April 10th, 2020
- The potential use of CRISPR to treat disease is gaining momentum - BioNews - January 16th, 2020
- What a time to be alive: Reproductive breakthroughs of the 2010s that changed life as we know it - FOX 10 News Phoenix - January 3rd, 2020
- 2019: The year gene therapy came of age - Jamaica Observer - December 9th, 2019
- Trevena Inc. (TRVN)'s Financial Results Comparing With VistaGen Therapeutics Inc. (NASDAQ:VTGN) - The Broch Herald - December 9th, 2019
- 253 miles in 4 hours: A Syracuse mans race for a lung transplant, and the angel who helped him - syracuse.com - December 1st, 2019
- Head to Head Survey: BioRestorative Therapies (OTCMKTS:BRTX) & Livongo Health (OTCMKTS:LVGO) - Mitchell Messenger - December 1st, 2019
- Critical Review: BioRestorative Therapies (OTCMKTS:BRTX) and Livongo Health (OTCMKTS:LVGO) - NCTY News - November 16th, 2019
- These Israeli Companies Are Finding Innovative Ways To Improve Diabetes Care, Treatment | Health News - NoCamels - Israeli Innovation News - November 16th, 2019
- Reviewing BioRestorative Therapies (OTCMKTS:BRTX) and Livongo Health (OTCMKTS:LVGO) - Mitchell Messenger - November 16th, 2019
- Reviewing Madrigal Pharmaceuticals Inc. (MDGL)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly - October 30th, 2019
- Gene Therapy/Editing Series 1: A Brief Introduction To Gene Therapy - Seeking Alpha - October 30th, 2019
- AI uncovers genes linked to heart failure - FierceBiotech - September 27th, 2019
- University of Pennsylvania || Cell and Molecular Biology ... - September 7th, 2019
- Robert Lanza - Wikipedia - May 12th, 2019
- Stem Cell Therapy in Lancaster Pennsylvania | Stem Cell ... - April 24th, 2019
- Lung Institute Review | Do Stem Cell Treatments Work? - April 21st, 2019
- Cells Weekly October 11, 2015 - stemcellassays.com - February 5th, 2019
- Pittsburgh, Pennsylvania - Stem Cells Transplant Institute - November 18th, 2018
- Stem Cell Therapy in York County, Pennsylvania - October 8th, 2018
- Regrowing dental tissue with stem cells from baby teeth ... - October 2nd, 2018
- About Penn's IRM - Institute for Regenerative Medicine - September 16th, 2018
- Stem Cell Treatment - Philadelphia Bala Cynwyd, PA: World ... - August 13th, 2018
- Stem Cell Therapy in Conewago Township, Pennsylvania - July 19th, 2018
- Meetings - October 8th, 2017
- Tucson's Calimmune to be acquired by Australian drug giant - Arizona Daily Star - August 30th, 2017
- Hair Regrowth using Stem Cells | Ashley and Martin - August 30th, 2017
- Bone Marrow Protein May Be Target for Improving Stem Cell Transplants - Penn: Office of University Communications - August 30th, 2017
- Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (CTL019), for children and young ... - GlobeNewswire (press release) - August 30th, 2017
- COLUMN: Startling statistics concerning drug deaths in rural communities - Meadville Tribune - August 25th, 2017
- Rare leukemia targeted by modifying patients' immune cells - New Haven Register - August 7th, 2017
- Campus achievement - Sunbury Daily Item - August 7th, 2017
- La Jolla Light News Nuggets: July 27 - La Jolla Light - July 30th, 2017
- 2016 Scientific Program - December 4th, 2016
- Tissue Niches & Resident Stem Cells in Adult Epithelia - GRC - August 26th, 2016
- Knee Stem Cell Therapy and Platelet Procedures Pittsburgh ... - July 2nd, 2015
- Penn vet team points to new colon cancer culprit - March 16th, 2015
- MD Anderson Names Hwu as Head of Cancer Medicine - February 26th, 2015
- Stemiotics Licenses Modified RNA for Cell Reprogramming - December 22nd, 2014
- Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019 - December 8th, 2014
- Cyanide killed hospital employee, official says - November 29th, 2014
- An Eclectic Path to Precision Medicine - November 25th, 2014
- First Study to Convert Adult Human Cells to Hair-Follicle ... - November 2nd, 2014
- Stem Cell and Xenograft Core: Biomedical Research Core ... - October 27th, 2014
- Immune Therapy Induces Remission for Many With a Tough-to-Treat Blood Cancer - October 18th, 2014
- Sangamo BioSciences ZFP Therapeutic Program in HIV/AIDS Featured at Three Major Scientific Conferences in October 2014 - October 16th, 2014